Today, patients and doctors live in a time in which hepatitis C can be readily diagnosed and treated, with an excellent chance of a cure. Of course, it wasn’t always this way.

The Covid-19 pandemic creates an extra layer of concern for oncology patients who are just starting, in the midst of, or wrapping up treatment. Early reports raised concern when they indicated that Covid-19 mortality rates …

Hepatitis C now ranks among the diseases that can nearly always be cured with appropriate treatment, which comes as a huge change compared to just a decade ago. However, after successfully treating hepatitis C virus (HCV) infection with direct-acting antiviral medications, there are still some things patients and their health care providers should keep in […]

Once again, we’re approaching the annual World Hepatitis Day that occurs each year on July 28th. The theme this year, “Find the Missing Millions,” reminds all of us that there continues to be 300 million people living with viral hepatitis worldwide who do not yet know that there’s a deadly disease in their blood. Getting […]

By now, most Baby Boomers have probably heard the message from health experts urging them to get screened for hepatitis C infection. This demographic – born between 1945 and 1965 – have long been identified as the group at highest risk of this life-threatening disease. However, switching from a birth cohort screening to a one-time […]

The term ‘hepatitis C’ is often discussed as if it’s one disease. However, the situation is a bit more complicated, with there being six main genotypes of hepatitis C. These are numerically labeled genotypes 1-6. The HCV testing process for patients generally starts with two main diagnostic tests: the Hepatitis C Antibody Test which notes […]

Scroll to Top